BANGKOK, July 9 - A government spokesman revealed that the Prime Minister welcomed Thai-Korea cooperation in the production of cell-based inactivated influenza influenza vaccines to strengthen public health security. Enhance production capacity and access to vaccines in ASEAN
Mr. Anucha Burapachaisri Deputy Secretary-General to the Prime Minister for Political Affairs Acting as a spokesperson for the Prime Minister's Office revealed that General Prayut Chan-o-cha, Prime Minister and Minister of Defense Appreciate the collaboration between the Government Pharmaceutical Organization (GPO) and SK bioscience Co., Ltd., Republic of Korea. In signing the Memorandum of Understanding Collaboration on Vaccines for Thai's Public Health Security on July 4, 2023, they will jointly produce influenza vaccines from cells. culture (Cell-based inactivated influenza) is believed to be an opportunity to create national public health security. and extending to the ASEAN region as well as seeking advanced technologies for the production of other vaccines through international collaboration in the future.
A spokesman for the Prime Minister's Office said: The Government Pharmaceutical Organization has a vaccine factory. which has conducted research and development to produce influenza vaccines for use in the event of an outbreak and seasonal influenza vaccines and receive government funding to prepare for re-emerging and emerging diseases by starting research and development for the production of COVID-19 vaccines From upstream to downstream using egg-based technology, it has also started the development of vaccines made from cell cultures (Cell-based technology).
In this regard, the signing of the Memorandum of Understanding in cooperation with SK bioscience Co., Ltd. from the Republic of Korea which is a vaccine manufacturer Prevent seasonal influenza from inactivated cell cultures, 3-strain and 4-strain in the form of ready-to-fill bulk vaccines and transfer packaging technology for the production of finished vaccines (Drug product) in order to have Make the most of your facility and support resources. As well as creating knowledge and expertise for personnel, SK bioscience Co., Ltd. is a consultant to transfer production process technology and knowledge to the FDA to create international standards such as certification from the organization. World Health Organization (WHO Prequalification Program :
According to data from the National Vaccine Institute, Currently, Thailand has 3 types of vaccines that can be produced by themselves: 1. BCG vaccine or tuberculosis vaccine. Produced by Queen Saovabha Memorial Institute 2. Cell-free pertussis vaccine from Bionet Asia Company Limited 3. JD vaccine against encephalitis It is a technology transfer and packaged by Global Biotech Products Co., Ltd., a joint venture of the A.P.
“The Prime Minister appreciates the integration of work in the public health sector as a concrete achievement. The government has continually focused on the development of public health. Public health security directly affects the quality of life of people. Including increasing production capacity and access to various vaccines that are important to health thoroughly. so that Thailand is ready to support emerging diseases and future challenges Including to upgrade the Thai medical industry to the goal of becoming a medical hub in the ASEAN region, ”said Mr. Anucha.-Thai News Agency
Source: Thai News Agency